Lin Zhou
Impact in
- Hepatology top 1%
- Hepatocellular Carcinoma Treatment and Prognosis
- Cancer Research top 2%
- MicroRNA in disease regulation
Papers in
- Hepatology 49
- Hepatocellular Carcinoma Treatment and Prognosis 45
- Surgery 53
- Organ Transplantation Techniques and Outcomes 43
- Co-authors
- Shusen Zheng (201 shared papers)Haiyang Xie (160 shared papers)Jian Wu (27 shared papers)Xiao Xu (40 shared papers)Shengyong Yin (36 shared papers)Jiacheng Huang (6 shared papers)Yiting Qiao (7 shared papers)Shengzhang Lin (3 shared papers)
- Journals
- PLoS ONE (10 papers)Cancer Letters (8 papers)Journal of Translational Medicine (6 papers)Oncotarget (6 papers)Digestive Diseases and Sciences (5 papers)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Lin Zhou
297 papers receiving 9.9k citations
Lin Zhou's Hit Papers
Peers
Comparison fields: 5 of 106
- Hepatology 962
- Cancer Research 586
- Biomaterials 508
- Molecular Biology 2.2k
- Oncology 694
Countries citing papers authored by Lin Zhou
This map shows the geographic impact of Lin Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lin Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lin Zhou more than expected).
Fields of papers citing papers by Lin Zhou
This network shows the impact of papers produced by Lin Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lin Zhou. The network helps show where Lin Zhou may publish in the future.
Co-authors
The 25 scholars most cited alongside Lin Zhou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 305 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Extracellular matrix and its therapeutic potential for cancer treatment Hit paper breakdown → | 2021 | 715 |
| 2 | Gut microbiome analysis as a tool towards targeted non-invasive biomarkers for early hepatocellular carcinoma Hit paper breakdown → | 2018 | 611 |
| 3 | WTAP facilitates progression of hepatocellular carcinoma via m6A-HuR-dependent epigenetic silencing of ETS1 Hit paper breakdown → | 2019 | 501 |
| 4 | 2019 | 239 | |
| 5 | 2015 | 223 | |
| 6 | 2020 | 219 | |
| 7 | 2017 | 194 | |
| 8 | 2017 | 183 | |
| 9 | 2020 | 154 | |
| 10 | 2011 | 141 | |
| 11 | 2017 | 141 | |
| 12 | 2015 | 133 | |
| 13 | 2022 | 129 | |
| 14 | 2007 | 116 | |
| 15 | 2014 | 115 | |
| 16 | 2011 | 114 | |
| 17 | 2009 | 108 | |
| 18 | 2014 | 105 | |
| 19 | 2019 | 98 | |
| 20 | 2013 | 95 |
About Lin Zhou
Lin Zhou is a scholar working on Hepatology, Surgery, Oncology, Biotechnology and Epidemiology, having authored 305 papers that have together received 10.1k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (45 papers), Organ Transplantation Techniques and Outcomes (43 papers), Hepatitis B Virus Studies (12 papers), Nanoparticle-Based Drug Delivery (10 papers), Microbial Inactivation Methods (10 papers), Gut microbiota and health (10 papers), MicroRNA in disease regulation (7 papers) and Cytomegalovirus and herpesvirus research (6 papers). The work is most often cited by research in Hepatology (962 citations), Cancer Research (586 citations), Biomaterials (508 citations), Molecular Biology (2.2k citations) and Oncology (694 citations). Lin Zhou has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Shusen Zheng, Haiyang Xie, Jian Wu, Xiao Xu, Shengyong Yin, Jiacheng Huang, Yiting Qiao, Shengzhang Lin, Dalong Wan and Lele Zhang. Their work appears in journals such as PLoS ONE, Cancer Letters, Journal of Translational Medicine, Oncotarget and Digestive Diseases and Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.